TORONTO — Today, Dr. David Williams, Ontario’s Chief Medical Officer of Health, issued the following statement on the province’s first confirmed case of vaccine-induced immune thrombotic thrombocytopenia (VITT) in a patient after receiving the AstraZeneca/COVISHIELD vaccine: “We have confirmed the first case of the rare blood clotting condition known as vaccine-induced immune thrombotic thrombocytopenia (VITT) …
Ontario Confirms First Case of Rare AstraZeneca-linked Blood Clotting
by | Apr 23, 2021 | Uncategorized | 0 comments